277
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

Making the case for the case report – informing physicians of intracranial hypertension as an adverse event in tyrosine kinase inhibitor treated chronic myeloid leukemia patients

&
Pages 1522-1523 | Received 11 Mar 2022, Accepted 12 Mar 2022, Published online: 25 Mar 2022

References

  • Haddad F, Kantarjian H, Issa GC, et al. 2022. Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia, Leuk Lymph (this issue)
  • Alshehry NF, Kortan P, Lipton JH. Imatinib-induced gastric antral vascular ectasia in a patient with chronic myeloid leukemia. Clin Case Rep. 2014;2(3):77–78.
  • Carey JC. The importance of case reports in advancing scientific knowledge of rare diseases. Rare Dis Epidemiol (Adv Exp Med Biol). 2010;686:77–86.
  • Wiwanitkit V. The usefulness of case reports in managing emerging infectious disease. J Med Case Rep. 2011;5:194.
  • Solomon J. Case studies: why are they important? Nature Clin Pract: Cardiovasc Med. 2006;3:379.
  • Berlin JA, Glasser SC, Ellenberg SS. Adverse event detection in drug development: recommendations and obligations beyond phase 3. Am J Public Health. 2008;98(8):1366–1371.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.